Plus Therapeutics, Inc. (PSTV) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1159227,
    "name": "Plus Therapeutics, Inc.",
    "stock_name": "Plus Therapeutics, Inc.",
    "full_name": "Plus Therapeutics, Inc.",
    "name_url": "stocks-analysis/plus-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.66",
    "chg": 0.07,
    "chgp": "11.02%",
    "dir": 1,
    "prev_price": "0.59",
    "mcapval": "47.55",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US72941H5090",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "18.55 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/plus-therapeutics-inc-1159227-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Plus Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-plus-therapeutics-inc-technically-bullish-or-bearish-3546613",
        "imagepath": "",
        "date": "2025-09-20 19:37:00",
        "description": "As of 8 September 2025, the technical trend for Plus Therapeutics, Inc. has changed from sideways to mildly bearish. The current stance is bearish, driven primarily by the daily moving averages indicating bearishness and the weekly Bollinger Bands also showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, the overall sentiment is tempered by the bearish signals from the Bollinger Bands and daily moving averages. The KST shows a mixed picture with weekly bullishness but monthly bearishness, and the Dow Theory indicates a mildly bullish stance on both time frames. There is no available return data to compare the company's performance against the S&P 500...."
      },
      {
        "title": "Is Plus Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-plus-therapeutics-inc-overvalued-or-undervalued-3543151",
        "imagepath": "",
        "date": "2025-09-20 18:12:05",
        "description": "As of 14 August 2023, the valuation grade for Plus Therapeutics, Inc. has moved from does not qualify to risky, indicating a significant downgrade in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -0.45 and an EV to EBITDA of -0.06, which highlight its struggles in generating positive value. Comparatively, peers like Sonoma Pharmaceuticals, Inc. have a P/E ratio of -2.1124 and Petros Pharmaceuticals, Inc. at -0.1676, reinforcing the challenging environment within the industry.\n\nThe stock has underperformed significantly against the S&P 500, with a year-to-date return of -62.51% compared to the index's 12.22%, and a staggering decline of -99.02% over the past five years. This stark contrast in performance further supports the conclusion that Plus Therapeutics, Inc. is overvalued in its current state...."
      }
    ],
    "total": 7,
    "sid": "1159227",
    "stock_news_url": "https://www.marketsmojo.com/news/plus-therapeutics-inc-1159227"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Plus Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:37:00

As of 8 September 2025, the technical trend for Plus Therapeutics, Inc. has changed from sideways to mildly bearish. The current stance is bearish, driven primarily by the daily moving averages indicating bearishness and the weekly Bollinger Bands also showing a bearish signal. While the MACD is mildly bullish on both weekly and monthly time frames, the overall sentiment is tempered by the bearish signals from the Bollinger Bands and daily moving averages. The KST shows a mixed picture with weekly bullishness but monthly bearishness, and the Dow Theory indicates a mildly bullish stance on both time frames. There is no available return data to compare the company's performance against the S&P 500....

Is Plus Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:12:05

As of 14 August 2023, the valuation grade for Plus Therapeutics, Inc. has moved from does not qualify to risky, indicating a significant downgrade in its financial standing. The company appears to be overvalued given its negative valuation ratios, including a Price to Book Value of -0.45 and an EV to EBITDA of -0.06, which highlight its struggles in generating positive value. Comparatively, peers like Sonoma Pharmaceuticals, Inc. have a P/E ratio of -2.1124 and Petros Pharmaceuticals, Inc. at -0.1676, reinforcing the challenging environment within the industry. The stock has underperformed significantly against the S&P 500, with a year-to-date return of -62.51% compared to the index's 12.22%, and a staggering decline of -99.02% over the past five years. This stark contrast in performance further supports the conclusion that Plus Therapeutics, Inc. is overvalued in its current state....

View All News